Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-010331
Filing Date
2023-03-28
Accepted
2023-03-28 16:45:46
Documents
121
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acrv-20221231.htm   iXBRL 10-K 3886632
2 EX-4.1 acrv-ex4_1.htm EX-4 53345
3 EX-10.12 acrv-ex10_12.htm EX-10 399082
4 EX-10.13 acrv-ex10_13.htm EX-10 190466
5 EX-10.14 acrv-ex10_14.htm EX-10 27281
6 EX-21.1 acrv-ex21_1.htm EX-21 2968
7 EX-23.1 acrv-ex23_1.htm EX-23 3298
8 EX-31.1 acrv-ex31_1.htm EX-31 19182
9 EX-31.2 acrv-ex31_2.htm EX-31 19203
10 EX-32.1 acrv-ex32_1.htm EX-32 13267
11 EX-32.2 acrv-ex32_2.htm EX-32 13250
12 GRAPHIC img190824698_0.jpg GRAPHIC 3967
13 GRAPHIC img191748219_0.jpg GRAPHIC 3967
14 GRAPHIC img241269316_0.jpg GRAPHIC 1758476
15 GRAPHIC img241269316_1.jpg GRAPHIC 1586562
16 GRAPHIC img241269316_2.jpg GRAPHIC 543896
17 GRAPHIC img241269316_3.jpg GRAPHIC 1932672
18 GRAPHIC img241269316_4.jpg GRAPHIC 2600970
19 GRAPHIC img241269316_5.jpg GRAPHIC 2326833
20 GRAPHIC img241269316_6.jpg GRAPHIC 1465471
21 GRAPHIC img241269316_7.jpg GRAPHIC 787393
22 GRAPHIC img241269316_8.jpg GRAPHIC 746452
23 GRAPHIC img241269316_9.jpg GRAPHIC 473265
24 GRAPHIC img241269316_10.jpg GRAPHIC 714718
25 GRAPHIC img241269316_11.jpg GRAPHIC 850227
26 GRAPHIC img241269316_12.jpg GRAPHIC 1141456
27 GRAPHIC img241269316_13.jpg GRAPHIC 3859027
28 GRAPHIC img241269316_14.jpg GRAPHIC 891132
29 GRAPHIC img241269316_15.jpg GRAPHIC 1558942
30 GRAPHIC img241269316_16.jpg GRAPHIC 1258253
31 GRAPHIC img241269316_17.jpg GRAPHIC 666794
32 GRAPHIC img241269316_18.jpg GRAPHIC 928148
33 GRAPHIC img241269316_19.jpg GRAPHIC 6300391
34 GRAPHIC img241269316_20.jpg GRAPHIC 1221148
35 GRAPHIC img241269316_21.jpg GRAPHIC 1140065
36 GRAPHIC img241269316_22.jpg GRAPHIC 1861928
37 GRAPHIC img241269316_23.jpg GRAPHIC 1315204
38 GRAPHIC img241269316_24.jpg GRAPHIC 928228
39 GRAPHIC img241269316_25.jpg GRAPHIC 2338052
  Complete submission text file 0000950170-23-010331.txt   111349450

Data Files

Seq Description Document Type Size
40 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acrv-20221231_cal.xml EX-101.CAL 67658
41 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acrv-20221231_def.xml EX-101.DEF 329940
42 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acrv-20221231_lab.xml EX-101.LAB 587473
43 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acrv-20221231.xsd EX-101.SCH 73041
44 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acrv-20221231_pre.xml EX-101.PRE 494953
115 EXTRACTED XBRL INSTANCE DOCUMENT acrv-20221231_htm.xml XML 2252282
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41551 | Film No.: 23770204
SIC: 2834 Pharmaceutical Preparations